DR. CARLTON D. DONALD
Dr. Donald founded PHIGENIX Pharmaceutical and Biomedical Research Company in 2007. He is the inventor of the intellectual property around which the company is based. Dr. Donald received his BS degree in biology from Florida A&M University, his M.S. and Ph.D. in Molecular Biology from Clark Atlanta University and completed two postdoctoral fellowships at Emory University including one in molecular urologic therapeutics. Prior to joining Phigenix, Dr. Donald was a professor at the Medical University of South Carolina and has over 20 years of experience as cancer biologist. He has published a number of ground-breaking, peer-reviewed articles, has over 36 abstracts and has received national and international recognition for his work.
Mrs. Wennifer H. Donald, Vice-president and COO, Director
Mrs. Donald has over 20 years of experience in business management. She has served as an corporate executive at the national headquarters of a Fortune 500 financial institution in Atlanta, Georgia. In addition, she has also served as lead operations manager for a multi-million dollar firm located in Atlanta, Georgia.
Dr. Richard Roy, Director, Lead Medical Advisor
Dr. Roy is a Board Certified Urologist and clinical scientist. He currently operates a urological practice in Columbus, OH, which consists of 30 urologists and a pathology diagnostic laboratory for urologic cancers.
Mr. Robert Knowles, Director
Mr. Knowles has served as a top executive for Exxon Mobile and BellSouth. He has also worked with the Georgia Department of Commerce and is an entrepreneur.
Dr. J. PAGE Brown, Head of Research and Development
Dr. Brown is a pharmaceutical veteran with substantial experience in product development and project management including serving as a lead scientist and biochemist for Procter and Gamble.